Vonoprazan‐associated long QT syndrome

To our knowledge, this is the first report describing a case of vonoprazan‐associated QT prolongation newly occurring after initiation of the drug and improving after its discontinuation in a patient concurrently receiving polypharmacy including a drug metabolized by CYP3A4.

Saved in:
Bibliographic Details
Published in:Journal of general and family medicine 2022-01, Vol.23 (1), p.54-55
Main Authors: Kubo, Kimitoshi, Sakakibara, Toru, Yonezawa, Kazuya, Kato, Mototsugu
Format: Article
Language:English
Subjects:
cardiovascular medicine
Electrocardiography
gastrointestinal medicine
Images in Clinical Medicine
Long QT syndrome
Potassium
P‐CAB
vonoprazan
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To our knowledge, this is the first report describing a case of vonoprazan‐associated QT prolongation newly occurring after initiation of the drug and improving after its discontinuation in a patient concurrently receiving polypharmacy including a drug metabolized by CYP3A4.
ISSN:2189-7948
2189-6577
2189-7948
DOI:10.1002/jgf2.485